The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

16 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASEBDB
Halda Therapeutics OPCO
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteinsBDB
Incyte
Therapeutic compoundsBDB
Celgene Quanticel Research
Therapeutic compoundsBDB
Celgene Quanticel Research
Tricyclic heterocycles as BET protein inhibitorsBDB
Incyte Holdings
Tricyclic heterocycles as bet protein inhibitorsBDB
Incyte
Substituted [1,2,4]triazolo[4,3-a]pyrazines as BRD4 inhibitorsBDB
Boehringer Ingelheim International
1H-pyrrolo[2,3,c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteinsBDB
Incyte
Tricyclic heterocycles as bet protein inhibitorsBDB
Incyte
Tricyclic heterocycles as bet protein inhibitorsBDB
Incyte
Therapeutic compounds and uses thereofBDB
Genentech
Therapeutic compoundsBDB
Celgene Quanticel Research
Tricyclic heterocycles as bet protein inhibitorsBDB
Incyte
Therapeutic compounds and uses thereofBDB
Genentech
Therapeutic compounds and uses thereofBDB
Genentech
Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereofBDB
Constellation Pharmaceuticals